Picture Berlin Partner Health Capital Computational Biology 2022 650x100px
Document › Details

Fluidigm Corporation. (8/28/17). "Press Release: Fluidigm to Participate in Two Upcoming Health Care Conferences in September". South San Francisco, CA.

Region Region New York, NY
  Country United States (USA)
Organisations Organisation Fluidigm Corporation (Nasdaq: FLDM)
  Group Fluidigm (Group)
  Organisation 2 Morgan Stanley & Co. LLC
  Group Morgan Stanley (Group)
Products Product Morgan Stanley Global Healthcare Conference 2017 New York
  Product 2 Cantor Fitzgerald Healthcare Conference 2017 New York
Index terms Index term Fluidigm–Morgan Stanley: investor conference, 201709 supply service Fludigm presents at Morgan Stanley Global Healthcare Conference
  Index term 2 Fluidigm–Cantor Fitzgerald: investor conference, 201709 supply service Fluidigm presents at Cantor Fitzegerald Global Healthcare Conference in NY
Persons Person Linthwaite, S. Christopher (Chris) (Fluidigm 201610– CEO joined 201608 as COO before Thermo Fisher + Life Technologies)
  Person 2 Jog, Vikram (Fluidigm 200802– CFO before XDx CFO + Applera)

Fluidigm Corporation (NASDAQ:FLDM) today announced that Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer, will participate in two upcoming health care conferences in New York, NY.

Morgan Stanley 15th Annual Global Health Care Conference
Linthwaite will participate in a fireside chat presentation on Monday, September 11, at 4:50 pm ET at the Grand Hyatt New York.

Cantor Fitzgerald Healthcare Conference
Linthwaite will also present on Tuesday, September 26, at 4:00 pm ET at the InterContinental New York Barclay Hotel.

Live webcasts of the company's presentations and subsequent replays may be accessed at The webcasts will be archived for 90 days following the live presentations.

About Fluidigm

Fluidigm (NASDAQ:FLDM) develops, manufactures, and markets life science analytical and preparatory systems for markets such as mass cytometry, high-throughput genomics, and single-cell genomics. We sell to leading academic institutions, clinical research laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies worldwide. Our systems are based on proprietary microfluidics and multiparameter mass cytometry technology and are designed to significantly simplify experimental workflow, increase throughput, and reduce costs while providing excellent data quality. Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures.

Fluidigm and the Fluidigm logo are trademarks or registered trademarks of Fluidigm Corporation.


Fluidigm Corporation
Ana Petrovic
Director, Corporate Development and Investor Relations
650.243.6628 (Office)

Record changed: 2017-08-29


Picture [iito] [LSE] Business Portal 650x200px

More documents for Fluidigm (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group ChinaBio Partnering Forum 2022 650x300

» top